Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation

NCT01223612 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Retinopathy

Interventions

DRUG: Ranibizumab
PROCEDURE: Modified ETDRS laser

Sponsor

Moorfields Eye Hospital NHS Foundation Trust

Collaborators

[object Object]